EMA Authorised: Plerixafor Accord (Plerixafor) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorises Plerixafor Accord for use in multiple myeloma and hematopoietic stem cell transplantation with Accord Healthcare S.L.U. as the marketing auth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation
• Multiple Myeloma

Drugs mentioned

• Plerixafor Accord (Plerixafor)

Snippet

Status: Authorised. Therapeutic area: Multiple Myeloma;Hematopoietic Stem Cell Transplantation. MAH: Accord Healthcare S.L.U.. Decision date: 22/07/2026